Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)

D. Thaçi*, A. Pinter, M. Sebastian, C. Termeer, M. Sticherling, S. Gerdes, S. Wegner, S. Krampe, H. Bartz, C. Rausch, A. Mensch, K. Eyerich

*Korrespondierende/r Autor/-in für diese Arbeit
4 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Guselkumab is superior to fumaric acid esters in patients with moderate-to-severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active-comparator-controlled phase IIIb trial (POLARIS)“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medizin & Biologie